Guinea Ebola Vaccine Clinical Trial Holds Best Hope For Useful Data Amid Shrinking Epidemic, WHO Says

Reuters: Completing Ebola vaccine trials ‘a challenge’ as epidemic wanes
“Falling Ebola cases in West Africa make completing big clinical trials on experimental vaccines a challenge, with the best hope resting on a study in Guinea, the World Health Organization said on Friday. While the waning epidemic is good news for long-suffering populations in the region, it makes it harder for health care experts and drug companies to see if vaccines can protect people against the deadly fever…” (Nebehay, 4/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.